# New Animal Drug Applications; Beta-Aminopropionitrile Fumarate; n-Butyl Chloride; Cupric Glycinate Injection; Dichlorophene and Toluene; Orgotein for Injection; Tetracycline Tablets
> **Food and Drug Administration** · Final rule, technical amendment. · Published 2021-02-23 · Effective 2021-02-23 · 86 FR 10818
## Document
- **Document number:** 2021-03251
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 86 FR 10818
- **CFR reference:** 21 CFR 510
- **Publication date:** 2021-02-23
- **Effective date:** 2021-02-23
- **HHS docket:** Docket No. FDA-2019-N-5405
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of seven new animal drug applications (NADAs) for lack of compliance with the reporting requirements in an FDA regulation.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2021/02/23/2021-03251/new-animal-drug-applications-beta-aminopropionitrile-fumarate-n-butyl-chloride-cupric-glycinate)
---
*AI Analytics · CC0 1.0*